Hanwha Group's life insurer, offering life, health and pension products to Korean retail and corporate customers.
Hanwha Group's life insurer, offering life, health and pension products to Korean retail and corporate customers.
Earns from premiums on life, health and pension policies and from investing those premiums, keeping the difference between what it earns and what it credits to policyholders. Sold through its own agents, bank counters and corporate clients. It belongs to Hanwha Group, a Korean family-led conglomerate (chaebol).
Moat: narrow (scale, brand, distribution). One of Korea's largest life insurers with a broad agent/bancassurance distribution network.
Headquarters: Seoul, South Korea · Founded: 1946 · Employees: 2,794
Size Hanwha Life (088350.KS) is a South Korea Financials company (Life/Health Insurance) with a market value of $2.09B, the 137th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩3,690 on 18 Nov 2026.
Performance Over six months the shares fell 32.8%, against -7.2% for the median peer and -37.2% for the South Korea market (cap-weighted) — lowest of 18 in its peer set.
Growth Revenue grew 20.4% over the last twelve months (peer median +17.5%); the operating margin is 17.0% (peer median 5.9%).
Valuation It trades at 0.23× book value against a peer median of 1.95× (2nd cheapest of 18).
Price implies The share price implies a return on equity of about 3.8%; Hanwha Life delivers 4.6%, so the price asks less than the business earns today.
Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩22.0T | ₩16.3T | ₩14.2T | ₩11.3T | ₩9.52T |
| Revenue growth | — | +15% | +26% | +19% | — |
| Net income | ₩516B | ₩527B | ₩709B | ₩721B | ₩942B |
| Free cash flow | -₩554B | ₩3.66T | ₩4.05T | ₩1.20T | ₩2.56T |
| Capital expenditure | ₩395B | ₩304B | ₩313B | ₩138B | ₩136B |
| Total debt | ₩34.7T | ₩31.2T | ₩14.6T | ₩11.7T | ₩11.6T |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE |
|---|---|---|---|---|---|---|
| Hanwha Life 088350.KS | $2.09B | -33% | +20% | 5% | 0.23× | 3.8% |
| Samsung Life 032830.KS | $34.1B | -23% | +33% | 4% | 0.37× | 5.0% |
| Mirae Asset Life Insurance 085620.KS | $1.70B | +19% | +152% | 2% | 1.06× | 5.8% |
| TongYang Life Insurance 082640.KS | n/a | +19% | n/a | n/a | n/a | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 088350.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -20.3% | -0.5% | lowest of 18 |
| 6-month return | -32.8% | -7.2% | lowest of 18 |
| Return on equity | 4.6% | 7.6% | 5th lowest of 18 |
| Price / book | 0.23× | 1.95× | 2nd cheapest of 18 |
| Trailing P/E | 5.4× | 25.8× | 4th cheapest of 18 |
| ROE the price implies | 3.8% | 15.5% | 2nd least demanding of 18 |
| ROE delivered | 4.6% | 7.6% | 5th lowest of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Hanwha Life 088350.KS | South Korea | $2.09B | -33% | +20% | 5% | 0.23× | 3.8% | 4.6% |
| Clover Health Investments CLOV | United States | $2.21B | +16% | +54% | 3% | 5.31× | 81.1% | 3.4% |
| Brighthouse Financial BHF | United States | $2.42B | -33% | -9% | 12% | 0.48× | 6.0% | 12.0% |
| Mirae Asset Life Insurance 085620.KS | South Korea | $1.70B | +19% | +152% | 2% | 1.06× | 5.8% | 1.8% |
| Nuernberger Beteiligungs NBG6.DE | Germany | $1.55B | +2% | -1% | 5% | 1.58× | 6.1% | 5.1% |
| Niva Bupa Health Insurance NIVABUPA.NS | India | $1.46B | -9% | +58% | 14% | 3.55× | 32.5% | 13.9% |
| COFCO Capital 002423.SZ | China | $3.08B | -7% | -31% | 6% | 0.83× | 6.1% | 5.6% |
| Privia Health PRVA | United States | $3.14B | +6% | +19% | 5% | 3.85× | 25.7% | 4.6% |
| Canara HSBC Life Insurance CANHLIFE.NS | India | $1.29B | -8% | +17% | 8% | 7.36× | 50.5% | 8.2% |
| Star Health & Allied Insurance STARHEALTH.NS | India | $3.53B | +8% | +21% | 12% | 3.16× | 47.6% | 11.7% |
| E-L Financial ELF.TO | Canada | $4.65B | +15% | +32% | 20% | 0.69× | 6.5% | 20.2% |
| Yunfeng Financial 0376.HK | Hong Kong | $872M | -24% | +21% | 7% | 0.53× | 7.4% | 6.7% |
| Max Financial Services MFSL.NS | India | $5.25B | -12% | +18% | 3% | 8.53× | 87.5% | 3.3% |
| Challenger CGF.AX | Australia | $5.26B | +28% | -25% | 13% | 1.95× | 15.5% | 13.3% |
| Lifenet Insurance 7157.T | Japan | $652M | -28% | +11% | 8% | 1.11× | 7.0% | 7.6% |
| ICICI Life Insurance ICICILIFE.NS | India | $6.90B | -15% | -8% | 13% | 4.72× | 66.2% | 12.6% |
| Farglory Life Insurance 5859.TWO | Taiwan | $614M | -1% | -48% | 7% | 0.22× | 1.7% | 7.1% |
| St. James's Place STJ.L | United Kingdom | $7.12B | -10% | +164% | 38% | 3.55× | 42.8% | 38.4% |